ctrl K

OnKure Therapeutics Inc. (OKUR)

NASDAQ: OKUR · Real-Time Price · USD

2.50

0.00 (0.00%)

At close: May 02, 2025, 3:59 PM

2.50

0.00%

After-hours: May 02, 2025, 04:00 PM EDT

OnKure Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-33.8M	-4.66M	-14.34M	-9.83M	21.11M	-20.89M	-8.63M	-8.75M
Interest Income	n/a	n/a	230K	295K	n/a	n/a	451K	73K
Pretax Income	-35.19M	-3.69M	-14.14M	-9.54M	18.52M	-19.2M	-8.18M	-8.68M
Net Income	-35.19M	-3.69M	-14.14M	-9.54M	18.52M	-19.2M	-8.18M	-8.68M
Selling & General & Admin	-3.56M	3.76M	3.59M	1.26M	-14.22M	7.27M	1.12M	1.23M
Research & Development	37.36M	904K	10.75M	8.57M	-6.89M	13.62M	7.51M	7.52M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	33.8M	4.66M	14.34M	9.83M	-21.11M	20.89M	8.63M	8.75M
Interest Expense	n/a	n/a	26K	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	33.8M	4.66M	14.34M	9.83M	-21.11M	20.89M	8.63M	8.75M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	13.34M	13.34M	13.34M	13.34M	13.34M	13.34M	13.34M	13.34M
Shares Outstanding (Diluted)	13.34M	13.34M	13.34M	13.34M	13.34M	13.34M	13.34M	13.34M
EPS (Basic)	n/a	-0.28	-1.06	-0.71	n/a	-1.44	-0.61	-0.65
EPS (Diluted)	n/a	-0.28	-1.06	-0.71	n/a	-1.44	-0.61	-0.65
EBITDA	-31.16M	-4.66M	-13.96M	-9.68M	21.55M	-20.89M	-8.03M	-8.62M
EBIT	-31.78M	-4.66M	-14.11M	-9.83M	21.11M	-20.89M	-8.18M	-8.75M
Depreciation & Amortization	622K	-259K	148K	151K	434K	-157K	155K	128K